Phase 3 Mariposa study evaluating Rybrevant plus Lazertinib meets primary endpoint in PFS in Non-Small Cell Lung Cancer: Janssen Ruchika Sharma2 Oct 2023 10:00 AM ISTRartan: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced positive topline results from the Phase 3 MARIPOSA study...
Johnson & Johnson Vision launches SILK procedure performed with next generation laser vision correction solution in India Ruchika Sharma23 Sept 2023 11:28 AM ISTThe procedure is easy, performed using the next-generation laser vision correction solution that gently creates a small disk-shaped lens, called a...
JnJ, P&G, Walgreens accused in lawsuits over cold medicine decongestant Ruchika Sharma15 Sept 2023 2:30 PM ISTJohnson & Johnson, Procter & Gamble and Walgreens are among several companies accused in lawsuits of deceiving consumers about cold...
Janssen declares positive topline results from Phase 3 study evaluating RYBREVANT given with, without lazertinib combined with chemotherapy versus chemotherapy alone Ruchika Sharma9 Sept 2023 1:45 PM ISTNew Jersey: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced positive topline results from the three-arm Phase 3 ...
Johnson & Johnson to halt hypertension drug Macitentan study Ruchika Sharma8 Sept 2023 11:43 AM ISTThe study was deemed "futile" and failed to improve exercise capacity in a broad population including inoperable patients compared to a placebo, J&J...
Novartis sues US government over Medicare drug price regulation Ruchika Sharma4 Sept 2023 11:31 AM ISTThe pharmaceutical industry says the program will curtail profits and compel it to pull back on developing new treatments.
Conduct Phase-III clinical trial in India: CDSCO panel tells Johnson and Johnson Over Guselkumab Dr. Divya Colin2 Sept 2023 6:00 PM ISTNew Delhi: Citing that there is no clinical data available on the Indian Population, the Subject Expert Committee (SEC) functional under the Central...
Janssen seeks USFDA full approval for Balversa for Urothelial Carcinoma Ruchika Sharma1 Sept 2023 12:30 PM ISTRaritan: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the submission of a supplemental New Drug Application...
Lupin, JnJ cut prices for TB drug in lower-income countries Ruchika Sharma1 Sept 2023 11:30 AM ISTThe drug will be available at the lower prices through the Stop TB Partnership's Global Drug Facility, which is the largest procurer of TB treatments.
Janssen seeks expanded USFDA approval for Rybrevant in combination with chemotherapy Ruchika Sharma29 Aug 2023 12:00 PM ISTRaritan: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the submission of a supplemental Biologics License ...
CDSCO panel tells JnJ to submit clarification for weight based calculated fixed dose of Teclistamab Isra Zaman23 Aug 2023 12:54 PM ISTBased on the proposal presented by drug major Johnson & Johnson for the protocol amendment of the anticancer drug Teclistamab, the Subject Expert...
Health Bulletin 22/August/2023 Isra Zaman22 Aug 2023 4:24 PM ISTHere are the top health stories for the day:Rural, urban health training center mandatory for starting new medical college: NMC regulationsThe...
